UR
CVS icon

USCA RIA’s CVS Health CVS Stock Holding History

USCA RIA’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$7.75M Buy
92,909
+2,167
+2% +$177K 0.47% 56
2021
Q1 		$6.83M Buy
90,742
+56,794
+167% +$4.14M 0.45% 58
2020
Q4 		$2.32M Buy
33,948
+573
+2% +$37.3K 0.16% 135
2020
Q3 		$1.95M Sell
33,375
-13,208
-28% -$822K 0.15% 136
2020
Q2 		$3.03M Buy
46,583
+559
+1% +$35.2K 0.27% 88
2020
Q1 		$2.73M Sell
46,024
-46,848
-50% -$3.13M 0.32% 77
2019
Q4 		$6.9M Buy
92,872
+2,120
+2% +$149K 0.62% 42
2019
Q3 		$5.72M Sell
90,752
-1,888
-2% -$112K 0.56% 53
2019
Q2 		$5.05M Sell
92,640
-994
-1% -$53.5K 0.51% 56
2019
Q1 		$5.05M Sell
93,634
-2,286
-2% -$141K 0.55% 52
2018
Q4 		$6.29M Sell
95,920
-47,529
-33% -$3.55M 0.84% 26
2018
Q3 		$11.3M Buy
143,449
+106,368
+287% +$7.6M 1.15% 10
2018
Q2 		$2.39M Sell
37,081
-34,624
-48% -$2.28M 0.26% 126
2018
Q1 		$4.46M Buy
71,705
+1,443
+2% +$104K 0.49% 52
2017
Q4 		$5.09M Buy
70,262
+19,952
+40% +$1.45M 0.56% 50
2017
Q3 		$4.05M Hold
50,310
– – 0.52% 52
2017
Q2 		$4.05M Buy
50,310
+7,713
+18% +$609K 0.52% 53
2017
Q1 		$3.34M Buy
42,597
+32,028
+303% +$2.56M 0.49% 53
2016
Q4 		$834K Sell
10,569
-10,500
-50% -$850K 0.13% 188
2016
Q3 		$1.88M Buy
21,069
+17,811
+547% +$1.68M 0.31% 98
2016
Q2 		$312K Sell
3,258
-62
-2% -$6.18K 0.05% 297
2016
Q1 		$344K Sell
3,320
-7,817
-70% -$760K 0.06% 256
2015
Q4 		$1.09M Buy
11,137
+1,442
+15% +$141K 0.24% 130
2015
Q3 		$935K Buy
9,695
+30
+0.3% +$3.15K 0.23% 130
2015
Q2 		$1.01M Buy
9,665
+832
+9% +$85K 0.27% 117
2015
Q1 		$912K Buy
8,833
+1,977
+29% +$200K 0.24% 125
2014
Q4 		$660K Buy
+6,856
New +$604K 0.18% 143
2014
Q2 		– Sell
-12,197
Closed -$913K – 292
2014
Q1 		$913K Buy
+12,197
New +$862K 0.33% 87

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

USCA RIA's CVS Position: Q2 2021 in Review

USCA RIA increased its CVS Health (CVS) stake by 2.4% in Q2 2021, buying an estimated $177K and bringing the position to 92,909 shares worth $7.75M. The position accounts for 0.47% of the portfolio, ranked #56.

USCA RIA first reported a position in CVS in Q1 2014 and has held it in 28 quarters since. The position peaked at $11.3M in Q3 2018. 2,064 funds tracked by Wall St. Rank hold CVS as of Q2 2021.

  • USCA RIA held 92,909 shares of CVS Health worth $7.75M as of Q2 2021.
  • USCA RIA bought 2,167 CVS Health shares in Q2 2021, an estimated $177K.
  • CVS Health made up 0.47% of USCA RIA's portfolio in Q2 2021, its #56 holding.
  • USCA RIA first reported a position in CVS Health in Q1 2014 and has held it in 28 quarters since.
  • USCA RIA's CVS Health position peaked at $11.3M in Q3 2018.
  • 2,064 funds tracked by Wall St. Rank held CVS Health as of Q2 2021.

Based on USCA RIA's 13F filing for Q2 2021, filed 28 Jul 2021.